Fingerprint
Collaborations and top research areas from the last five years
Profiles
-
James Bieker
- Center for Advancement of Blood Cancer Therapies
- Institute for Regenerative Medicine
- Black Family Stem Cell Institute
- Cancer Mechanisms
- Friedman Brain Institute
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Mindich Child Health and Development Institute
- Mount Sinai Tisch Cancer Center
- Stem Cell Biology and Regenerative Medicine
Person
-
Joshua Brody
- Center for Advancement of Blood Cancer Therapies
- Cancer Clinical Investigation
- Graduate School of Biomedical Sciences
- Icahn Genomics Institute
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Medicine
- Medicine - Hematology and Medical Oncology
- Mount Sinai Academy of Physician-Scientists
- Mount Sinai Tisch Cancer Center
Person
-
David Dominguez-Sola
- Center for Advancement of Blood Cancer Therapies
- Cancer Biology
- Cancer Mechanisms
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Mount Sinai Academy of Physician-Scientists
- Mount Sinai Tisch Cancer Center
- Oncological Sciences
Person
-
James Ferrara
- Center for Advancement of Blood Cancer Therapies
- Cancer Immunology
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Medicine
- Medicine - Hematology and Medical Oncology
- Mount Sinai Tisch Cancer Center
- Stem Cell Transplantation
Person
-
Saghi Ghaffari
- Center for Advancement of Blood Cancer Therapies
- Institute for Regenerative Medicine
- Black Family Stem Cell Institute
- Cancer Mechanisms
- Friedman Brain Institute
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Mount Sinai Academy of Physician-Scientists
- Mount Sinai Tisch Cancer Center
- Stem Cell Biology and Regenerative Medicine
Person
-
Yelena Ginzburg
- Center for Advancement of Blood Cancer Therapies
- Cancer Clinical Investigation
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Institute for Translational Medicine and Pharmacology
- Medicine
- Medicine - Hematology and Medical Oncology
- Mount Sinai Academy of Physician-Scientists
- Mount Sinai Tisch Cancer Center
Person
-
Ernesto Guccione
- Center for Advancement of Blood Cancer Therapies
- Institute for Regenerative Medicine
- Black Family Stem Cell Institute
- Cancer Biology
- Cancer Mechanisms
- Friedman Brain Institute
- Graduate School of Biomedical Sciences
- Icahn Genomics Institute
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Mount Sinai Tisch Cancer Center
- Oncological Sciences
- Pharmacological Sciences
Person
-
Ronald Hoffman
- Center for Advancement of Blood Cancer Therapies
- Institute for Regenerative Medicine
- Black Family Stem Cell Institute
- Cancer Clinical Investigation
- Friedman Brain Institute
- Hematology-Oncology, Infectious Diseases, Palliative Care, Psychology, and Nutrition
- Icahn School of Medicine at Mount Sinai
- Institute for Translational Medicine and Pharmacology
- Medicine
- Medicine - Hematology and Medical Oncology
- Mount Sinai Academy of Physician-Scientists
- Mount Sinai Tisch Cancer Center
Person
-
Amir Horowitz
- Center for Advancement of Blood Cancer Therapies
- Institute for Regenerative Medicine
- Cancer Immunology
- Center for Inborn Errors of Immunity
- Graduate School of Biomedical Sciences
- Icahn School of Medicine at Mount Sinai
- Marc and Jennifer Lipschultz Precision Immunology Institute
- Mount Sinai Tisch Cancer Center
- Oncological Sciences
Person
Research output
-
A MICA/B GAALIE-mutant antibody elicits potent natural killer cell-driven immunity in solid and hematologic malignancy models
Pimenta, R., Maurer, S., Zhong, X., Taciane da Silva Bortoleti, B., Quasem, S., Ribeiro de Lima Brandão, L., Marcellino, B., Dutta, A., Arriaga, J. M., Mascarenhas, J. & Ferrari de Andrade, L., 19 May 2026, In: Cell Reports Medicine. 7, 5, 102753.Research output: Contribution to journal › Article › peer-review
Open Access -
Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth
Mateus-Tique, J., Lakshmi, A., Singh, B., Iyer, R., Sánchez-Paulete, A. R., Falcomatà, C., Lin, M., Pantsulaia, G., Tepper, A., Nguyen, T., Amabile, A., Mollaoglu, G., Pia, L., Chhamalwan, D., Le Berichel, J., Potak, H., Colonna, M., Baccarini, A., Brody, J. & Merad, M. & 1 others, , 9 Mar 2026, In: Cancer Cell. 44, 3, p. 534-550.e11Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations -
Artificial intelligence differentiates prefibrotic primary myelofibrosis with thrombocytosis from essential thrombocythemia using digitized bone marrow biopsy images
Srisuwananukorn, A., Loscocco, G. G., Dolezal, J. M., Kuykendall, A. T., Santi, R., Zhang, L., Singh, A. M., Guglielmelli, P., Vannucchi, A. M., Salama, M. E., Pearson, A. T. & Hoffman, R., May 2026, In: Leukemia. 40, 5, p. 1018-1026 9 p.Research output: Contribution to journal › Article › peer-review
Open Access -
A study of gene expression in the living human brain
Liharska, L. E., Park, Y. J., Ziafat, K., Wilkins, L., Silk, H., Linares, L. M., Thompson, R. C., Vornholt, E., Sullivan, B., Cohen, V., Kota, P., Feng, C., Cheng, E., Johnson, J. S., Rieder, M. K., Huang, J., Scarpa, J., Polanco, J., Moya, E. & Hashemi, A. & 8 others, , Jan 2026, In: Molecular Psychiatry. 31, 1, p. 137-157 21 p.Research output: Contribution to journal › Article › peer-review
Open Access5 Scopus citations -
A synergistic interaction between PRMT5 and LSD1 inhibitors in AML
Param, N. J., Arceci, E., Fiorentino, F., Pignata, L., Torre, D., Gutiérrez-Trejo, N., Fong, J. Y., Goy, P. A., Han, B. Y., Lambona, C., Bello, E. D., Castiello, C., Barone, M., Schwarz, M., Arrowsmith, C., Ito, K., Scherle, P., Wee, D. K. B., Ndoye, S. & Tabaglio, T. & 9 others, , 27 Mar 2026, In: Science advances. 12, 13, eaea4059.Research output: Contribution to journal › Article › peer-review
Open Access -
A Tumor-Promoting Inflammatory SPP1+ Macrophage–IL6–CRP Axis Drives Immune Dysfunction in Bladder Cancer
Tran, M. A., Cho, B. A., Izadmehr, S., Yoo, S. K., Youssef, D., Anker, J. F., Farkas, A. M., Figueiredo, I., Lee, K., Ananthanarayanan, A., Balan, S., Onkar, S., Banchereau, R., Gupta, S., Chhibber, A., Wang, L., Beaumont, K. G., Li, Z., Garcia-Barros, M. & Bicak, M. & 18 others, , Jun 2026, In: Cancer Discovery. 16, 6, p. 1126-1151 26 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Author Correction: The AIM2 inflammasome exacerbates atherosclerosis in clonal haematopoiesis (Nature, (2021), 592, 7853, (296-301), 10.1038/s41586-021-03341-5)
Fidler, T. P., Xue, C., Yalcinkaya, M., Hardaway, B., Abramowicz, S., Xiao, T., Liu, W., Thomas, D. G., Hajebrahimi, M. A., Pircher, J., Silvestre-Roig, C., Kotini, A. G., Luchsinger, L. L., Wei, Y., Westerterp, M., Snoeck, H. W., Papapetrou, E. P., Schulz, C., Massberg, S. & Soehnlein, O. & 6 others, , 2026, (Accepted/In press) In: Nature.Research output: Contribution to journal › Comment/debate
Open Access -
Author Correction: A streamlined base editor engineering strategy to reduce bystander editing (Nature Communications, (2025), 16, 1, (8115), 10.1038/s41467-025-63609-6)
Valdez, I., O’Connor, I., Patel, D., Gierer, K., Harrington, J., Ellis, E., Caponetti, S. A., Sebra, R. P., Valley, H. C., Coote, K., Mense, M., Marro, S. G. & Jiang, T., Dec 2026, In: Nature Communications. 17, 1, 997.Research output: Contribution to journal › Comment/debate
Open Access -
Bacillus Calmette-Guérin (BCG) and Beyond: Is Systemic Immunotherapy for BCG-Naïve Non–Muscle-Invasive Bladder Cancer Progress or Overreach?
Kamat, A. M., Hensley, P. J., Maiorano, B. A., Li, R., Psutka, S. P., Mouw, K. W., Horowitz, A., Gupta, S. & Necchi, A., Mar 2026, In: Journal of Clinical Oncology. JCO-25-02670.Research output: Contribution to journal › Article › peer-review
1 Scopus citations -
Baseline absolute lymphocyte count, C-reactive protein, and ferritin predict CAR T cell-related toxicities and outcomes in multiple myeloma
Pan, D., Mouhieddine, T. H., Sheng, T., Fu, W., Moshier, E., Richter, J., Parekh, S., Jagannath, S., Chari, A., Rossi, A. C., Sanchez, L. J., Thibaud, S., Rodriguez, C., Cho, H. J. & Richard, S., May 2026, In: Bone Marrow Transplantation. 61, 5, p. 639-641 3 p.Research output: Contribution to journal › Letter › peer-review
-
Complement-regulated homeostatic proliferation controls memory B cell longevity and repertoire composition
Cody, E. W., Ningoo, M., Monga, I., Tsankov, A. M., Muramatsu, H., Pardi, N., Fribourg, M., Heeger, P. S. & Dominguez-Sola, D., 6 Jul 2026, In: Journal of Experimental Medicine. 223, 7Research output: Contribution to journal › Article › peer-review
-
Correction: Inhibition of the Nuclear Export Receptor XPO1 as a Therapeutic Target for Platinum-Resistant Ovarian Cancer (Clin Cancer Res (2017), 23, (1552-1563), 10.1158/1078-0432.CCR-16-1333)
Chen, Y., Camacho, S. C., Silvers, T. R., Razak, A. R. A., Gabrail, N. Y., Gerecitano, J. F., Kalir, E., Pereira, E., Evans, B. R., Ramus, S. J., Huang, F., Priedigkeit, N., Rodriguez, E., Donovan, M., Khan, F., Kalir, T., Sebra, R., Uzilov, A., Chen, R. & Sinha, R. & 11 others, , 15 Mar 2026, In: Clinical Cancer Research. 32, 6, p. 1183 1 p.Research output: Contribution to journal › Comment/debate
Open Access
Press/Media
-
Lilly to present initial clinical data for first-in-class type II JAK2 inhibitor in patients with previously treated myelofibrosis at the 2026 EHA Annual Meeting
12/06/26 → 13/06/26
22 items of Media coverage
Press/Media
-
Lilly To Present Initial Clinical Data For First-In-Class Type II JAK2 Inhibitor In Patients With Previously Treated Myelofibrosis At The 2026 EHA Annual Meeting
13/06/26
4 items of Media coverage
Press/Media
-
Cancer-Associated Mutations in Brain Immune Cells May Contribute to Alzheimer's Disease
11/06/26 → 13/06/26
6 items of Media coverage
Press/Media
-
Lilly unveils first clinical data behind $2.3B Ajax deal, showing JAK inhibitor works ‘right out of the gate'
13/06/26
2 items of Media coverage
Press/Media
-
Age-Related Mutations in Brain Immune Cells Linked to Alzheimer’s Inflammation
13/06/26
1 item of Media coverage
Press/Media
-
Mount Sinai Scientists Reverse Aging in Blood Stem Cells by Fixing the Cell's Recycling System
12/06/26
1 item of Media coverage
Press/Media
-
Reports Summarize Nanobodies Findings from Icahn School of Medicine at Mount Sinai (Multispecific nanobody degraders co-deplete membrane receptors and enable targeted delivery of diverse payloads)
Kabir, M., Zhong, Y., Huang, K. & Guccione, E.
11/06/26
1 item of Media coverage
Press/Media
-
Methods of Monitoring Inflammatory Bowel Diseases
Özbek, U., Ungaro, R., Levine, J., Ferrara, J. & Colombel, J.-F.
9/06/26
1 item of Media coverage
Press/Media